Factors in Deciding between Novel and Traditional Oral Anticoagulants to Prevent Embolism in Atrial Fibrillation Patients

Detalles Bibliográficos
Autores principales: Scanavacca, Maurício, Darrieux, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Cardiologia - SBC 2016
Materias:
Editorial
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728588/
https://www.ncbi.nlm.nih.gov/pubmed/26815647
http://dx.doi.org/10.5935/abc.20160010
_version_ 1782412143933521920
author Scanavacca, Maurício
Darrieux, Francisco
author_facet Scanavacca, Maurício
Darrieux, Francisco
author_sort Scanavacca, Maurício
collection PubMed
description
format Online
Article
Text
id pubmed-4728588
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Sociedade Brasileira de Cardiologia - SBC
record_format MEDLINE/PubMed
spelling pubmed-47285882016-01-29 Factors in Deciding between Novel and Traditional Oral Anticoagulants to Prevent Embolism in Atrial Fibrillation Patients Scanavacca, Maurício Darrieux, Francisco Arq Bras Cardiol Editorial Sociedade Brasileira de Cardiologia - SBC 2016-01 /pmc/articles/PMC4728588/ /pubmed/26815647 http://dx.doi.org/10.5935/abc.20160010 Text en http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Editorial
Scanavacca, Maurício
Darrieux, Francisco
Factors in Deciding between Novel and Traditional Oral Anticoagulants to Prevent Embolism in Atrial Fibrillation Patients
title Factors in Deciding between Novel and Traditional Oral Anticoagulants to Prevent Embolism in Atrial Fibrillation Patients
title_full Factors in Deciding between Novel and Traditional Oral Anticoagulants to Prevent Embolism in Atrial Fibrillation Patients
title_fullStr Factors in Deciding between Novel and Traditional Oral Anticoagulants to Prevent Embolism in Atrial Fibrillation Patients
title_full_unstemmed Factors in Deciding between Novel and Traditional Oral Anticoagulants to Prevent Embolism in Atrial Fibrillation Patients
title_short Factors in Deciding between Novel and Traditional Oral Anticoagulants to Prevent Embolism in Atrial Fibrillation Patients
title_sort factors in deciding between novel and traditional oral anticoagulants to prevent embolism in atrial fibrillation patients
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4728588/
https://www.ncbi.nlm.nih.gov/pubmed/26815647
http://dx.doi.org/10.5935/abc.20160010
work_keys_str_mv AT scanavaccamauricio factorsindecidingbetweennovelandtraditionaloralanticoagulantstopreventembolisminatrialfibrillationpatients
AT darrieuxfrancisco factorsindecidingbetweennovelandtraditionaloralanticoagulantstopreventembolisminatrialfibrillationpatients

Ejemplares similares